v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net income $ 65,134 $ 32,896 $ 190,719 $ 81,159  
Adjustments to reconcile Net income to net cash provided by operating activities:          
Depreciation and amortization     66,928 69,344  
Amortization and extinguishment of debt issuance costs     1,667 2,498  
Amortization of original issue discount 455 2,051 1,528 2,858  
Non-cash interest (income) expense     (10,603) 9,761  
Non-cash loss on commodity contracts, net     398 (9)  
Non-cash foreign exchange (gain)/loss, net     (9,173) 23,035  
Non-cash stock-based compensation     7,580 2,562  
(Gain)/loss on sale of property, plant, and equipment     (242) 656  
Provision for credit losses     3,234 2,917  
Deferred income taxes     2,720 (4,144)  
Changes in assets and liabilities, net of the effects of acquisitions:          
Accounts and equipment financing receivables, net     (1,673) (3,807)  
Other assets     9,281 (3,153)  
Other liabilities     10,878 (5,857)  
Net cash provided by operating activities     230,202 116,790  
Cash flows from investing activities:          
Capital expenditures     (23,780) (29,789)  
Acquisition of businesses, net of cash acquired     (3,758) (13,614)  
Proceeds on disposition of assets     548 343  
Net cash used in investing activities     (21,946) (54,310)  
Cash flows from financing activities:          
Payments on long-term borrowings     (160,000) (135,000)  
Cash paid for debt establishment and amendment fees     (924) (1,877)  
Repurchase of common stock     (75,000) (6,205)  
Taxes paid related to net share settlement of stock options     (8,795) (1,937)  
Net proceeds from stock options exercised     3,162 5,672  
Proceeds from common stock issuance under employee purchase plan     209 500  
Net cash used in financing activities     (194,222) (91,622)  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     (523) 921  
Increase/(Decrease) in cash, cash equivalents, and restricted cash     13,511 (28,221)  
Cash, cash equivalents, and restricted cash at beginning of period     149,703 188,042 $ 188,042
Cash, cash equivalents, and restricted cash at end of period 163,214 159,821 163,214 159,821 149,703
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets:          
Cash and cash equivalents 133,650 136,168 133,650 136,168 123,102
Total cash, cash equivalents, and restricted cash shown in the Statement of Cash Flows 163,214 159,821 163,214 159,821 149,703
Supplemental disclosure of cash flow information:          
Cash paid for income taxes     52,935 38,872  
Supplemental disclosure of investing and financing non-cash activities:          
Capital expenditures included in accounts payable     6,715 2,662  
Nonrelated Party          
Changes in assets and liabilities, net of the effects of acquisitions:          
Inventories, net     3,693 (15,069)  
Accounts payable     39,552 9,677  
Related Party          
Changes in assets and liabilities, net of the effects of acquisitions:          
Inventories, net     (166) 166  
Accounts payable     39 370  
Variable Interest Entity, Primary Beneficiary          
Changes in assets and liabilities, net of the effects of acquisitions:          
Accounts receivable - restricted for securitization investors     (28,295) (34,391)  
Equipment financing receivables, net - restricted for securitization investors     (57,863) (21,783)  
Cash flows from investing activities:          
Originations of equipment financing receivables, net - restricted for securitization investors     (53,501) (66,924)  
Collections of equipment financing receivables, net     58,545 55,674  
Cash flows from financing activities:          
Increase in asset backed borrowings owed to securitization investors     175,464 164,311  
Decrease in asset backed borrowings owed to securitization investors     (128,338) (117,086)  
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets:          
Restricted cash 27,882 20,052 27,882 20,052 22,999
Supplemental disclosure of cash flow information:          
Cash paid for interest     22,892 23,706  
Consolidated Entity, Excluding Consolidated VIE          
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets:          
Restricted cash $ 1,682 $ 3,601 1,682 3,601 $ 3,602
Supplemental disclosure of cash flow information:          
Cash paid for interest     $ 59,910 $ 107,974